Ventana Medical Systems Inc

3 dispositifs dans la base de données

  • Modèle / numéro de série
    Lot numbers: R20061A, R20429A, R21002A, and R21002B.
  • Distribution
    Nationwide to pathology laboratories and hospitals.
  • Description du dispositif
    ChemMate (brand) Keratin Primary Antibody, Clones AE1, AE3, CAM 5.2 and 35betaH11. Catalog number PAB111.
  • Modèle / numéro de série
    Lot Numbers; 23095A, 23340A, and 30116A.
  • Classification du dispositif
  • Classe de dispositif
    3
  • Dispositif implanté ?
    No
  • Distribution
    Nationwide and to Japan, France and Puerto Rico.
  • Description du dispositif
    CONFIRM c-KIT, Antibody (rabbit polyclonal), Catalog number 790-2939
  • Modèle / numéro de série
    Lot 400566
  • Classification du dispositif
  • Classe de dispositif
    1
  • Dispositif implanté ?
    No
  • Distribution
    Nationwide.
  • Description du dispositif
    iVIEW DAB Detecion Kit. || Catalog Number 760-091

13 fabricants avec un nom similaire

En savoir plus sur les données ici

  • Adresse du fabricant
    Ventana Medical Systems Inc, 1910 E Innovation Park Dr, Oro Valley AZ 85755-1962
  • Société-mère du fabricant (2017)
  • Source
    USFDA
  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    Note published by the authorities from the Netherlands: This message is a warning from the manufacturer. After placing a medical device on the market, the manufacturer is obliged to follow the device and, where necessary, to improve it. When there is a risk for the user, the manufacturer must take action. The manufacturer informs users and the inspection of this action with a warning (Field Safety Notice). See also medical device warnings. This is part of the supervision of medical technology.
  • Source
    IGJ
  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    Note published by the authorities from the Netherlands: This message is a warning from the manufacturer. After placing a medical device on the market, the manufacturer is obliged to follow the device and, where necessary, to improve it. When there is a risk for the user, the manufacturer must take action. The manufacturer informs users and the inspection of this action with a warning (Field Safety Notice). See also medical device warnings. This is part of the supervision of medical technology.
  • Source
    IGJ
8 en plus